748 results on '"Delwail, A."'
Search Results
2. Obinutuzumab vs rituximab for transplant-eligible patients with mantle cell lymphoma
3. Liposomal co-encapsulation of a novel gemini lipopeptide and a CpG-ODN induces a strong Th1 response with the co-activation of a Th2/Th17 profile and high antibody levels
4. Nanoscale effect on the formation of the amorphous Ni silicide by rapid thermal annealing from crystalline and pre-amorphized silicon
5. Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group
6. Hodgkin lymphoma and female fertility: a multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazine
7. Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study
8. Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 studyResearch in context
9. Hairy cell leukemia with isolated bone lesions
10. Obinutuzumab versus Rituximab in transplant-eligible Mantle cell lymphoma patients
11. Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life—experience of the French Network
12. Evolution of the Ni0.9Pt0.1/Si system under annealing via nano-crystalline textured phases.
13. Impact of the pre amorphization by Ge implantation on Ni0.9Pt0.1 silicide
14. Ex vivo cytokine production in psoriatic disease: Towards specific signatures in cutaneous psoriasis and peripheral psoriatic arthritis
15. Nanoscale effect on the formation of the amorphous Ni silicide by rapid thermal annealing from crystalline and pre-amorphized silicon
16. Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product
17. R-CHOP appears to be the best first-line treatment for second primary diffuse large B cell lymphoma: a cancer registry study
18. GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors
19. Evolution of the Ni0.9Pt0.1/Si system under annealing via nano-crystalline textured phases
20. Description du phénotype et du profil cytokinique dans une famille suivie pour un syndrome TRAPS et porteuse de la mutation p.(Thr79Met) du gène codant pour la protéine TNFRSF1A : association avec la sacro-iliite
21. R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma
22. Cytokine Signature in Schnitzler Syndrome: Proinflammatory Cytokine Production Associated to Th Suppression
23. Skin inflammatory response and efficacy of anti-epidermal growth factor receptor therapy in metastatic colorectal cancer (CUTACETUX)
24. Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies
25. Study of the Role of the Tyrosine Kinase Receptor MerTK in the Development of Kidney Ischemia-Reperfusion Injury in RCS Rats
26. Long‐term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in elderly mantle cell lymphoma patients. For the LYSA group.
27. Data from The Negative Influence of Baseline Cell-free DNA on Long-term Survival in DLBCL Depends on Frontline Treatment Intensity
28. Supplementary Data 1 from The Negative Influence of Baseline Cell-free DNA on Long-term Survival in DLBCL Depends on Frontline Treatment Intensity
29. Hairy cell leukemia with isolated bone lesions
30. The negative influence of baseline cell-free DNA on long-term survival in DLBCL depends on frontline treatment intensity
31. Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group
32. Management and outcome of primary CNS lymphoma in the modern era: An LOC network study
33. Data from The Negative Influence of Baseline Cell-free DNA on Long-term Survival in DLBCL Depends on Frontline Treatment Intensity
34. Supplementary Data 1 from The Negative Influence of Baseline Cell-free DNA on Long-term Survival in DLBCL Depends on Frontline Treatment Intensity
35. Supplementary Table 1 from Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas
36. Characterization of skin Th17 transcriptional profiles in psoriatic patients under adalimumab biotherapy
37. Description du phénotype et du profil cytokinique dans une famille suivie pour un syndrome TRAPS et porteuse de la mutation p.(Thr79Met) du gène codant pour la protéine TNFRSF1A : association avec la sacro-iliite
38. A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma
39. High-Fat Diet–Induced IL-17A Exacerbates Psoriasiform Dermatitis in a Mouse Model of Steatohepatitis
40. Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial
41. Data from Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas
42. Supplementary Table 1 from Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas
43. Prognostic Impact of Prephase Treatment Prior to First-Line Treatment in DLBCL: A Population-Based Registry Study.
44. Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial
45. Ex vivo cytokine production in psoriatic disease: Towards specific signatures in cutaneous psoriasis and peripheral psoriatic arthritis
46. L’analyse du métabolome salivaire révèle des variations du métabolisme de la tyrosine chez des patients atteints de stomatodynie primaire : étude prospective cas-témoins
47. Phenotype and cytokine profile in a TRAPS Syndrome family with TNFRSF1A p.(Thr79Met): Association with sacro-iliitis
48. Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product
49. High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study
50. Isolated intraocular relapses of primary cerebral lymphomas: An loc network study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.